GS-0976, a Liver-Targeted Acetyl-CoA Carboxylase (ACC) Inhibitor, Reduces Plasma Acylcarnitines in Patients with Nonalcoholic Steatohepatitis (NASH)

被引:0
|
作者
Charlton, Michael R. [1 ]
Lai, Michelle [2 ,3 ]
Noureddin, Mazen [4 ]
Tarrant, Jacqueline M. [5 ]
Wang, Lulu [5 ]
Tuan Nguyen [5 ]
McColgan, Bryan John [5 ]
Chung, Chuhan [5 ]
Patterson, Scott D. [5 ]
Myers, Robert P. [5 ]
Mantry, Parvez [6 ]
Ruane, Peter J. [7 ]
Loomba, Rohit [8 ]
机构
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Harvard Med Sch, Boston, MA USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[5] Gilead Sci Inc, Foster City, CA 94404 USA
[6] Methodist Dallas Med Ctr, Liver Inst & Intervent Radiol, Dallas, TX USA
[7] Ruane Clin Res, Los Angeles, CA USA
[8] Univ Calif San Diego, Div Gastroenterol, NAFLD Res Ctr, San Diego, CA 92103 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1741
引用
收藏
页码:992A / 993A
页数:2
相关论文
共 37 条
  • [31] COMBINATION OF AN ACETYL-CoA CARBOXYLASE (ACC) INHIBITOR AND FIBROBLAST GROWTH FACTOR 19 (FGF19) REDUCED TISSUE TRIGLYCERIDE CONTENT AND FIBROSIS IN A 3D HUMAN LIVER MICROTISSUE MODEL OF NONALCOHOLIC STEATOHEPATITIS (NASH)
    Tsai, Wen-Wei
    Bieri, Manuela
    Grepper, Sue
    Thoma, Eva
    Trevaskis, James L.
    HEPATOLOGY, 2021, 74 : 1133A - 1133A
  • [32] A combination of the ACC inhibitor GS-0976 and the nonsteroidal FXR agonist GS-9674 improves hepatic steatosis, biochemistry, and stiffness in patients with non-alcoholic steatohepatitis
    Lawitz, Eric
    Gane, Edward
    Ruane, Peter
    Herring, Jr. Robert
    Younes, Ziad H.
    Kwo, Paul
    Zhang, Jie
    Jia, Catherine
    Chuang, Jay
    Mccolgan, Bryan
    Chung, Chuhan
    Subramanian, Mani
    Myers, Robert
    Middleton, Michael
    Li, Kelvin
    Hellerstein, Marc
    Noureddin, Mazen
    Harrison, Stephen
    Loomba, Rohit
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E794 - E794
  • [33] A combination of the ACC inhibitor GS-0976 and the nonsteroidal FXR agonist GS-9674 improves hepatic steatosis, biochemistry, and stiffness in patients with non-alcoholic steatohepatitis
    Lawitz, Eric
    Gane, Edward
    Ruane, Peter
    Herring, Robert, Jr.
    Younes, Ziad H.
    Kwo, Paul
    Zhang, Jie
    Jia, Catherine
    Chuang, Jay
    McColgan, Bryan
    Chung, Chuhan
    Subramanian, Mani
    Myers, Robert
    Thali, Ramon
    Middleton, Michael
    Li, Kelvin
    Hellerstein, Marc
    Noureddin, Mazen
    Harrison, Stephen
    Loomba, Rohit
    SWISS MEDICAL WEEKLY, 2019, : 25S - 25S
  • [34] Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA Carboxylase
    Weber, Elijah J.
    Younis, Islam R.
    Nelson, Cara
    Qin, Ann R.
    Watkins, Timothy R.
    Othman, Ahmed A.
    CLINICAL PHARMACOKINETICS, 2024, 63 (10) : 1423 - 1434
  • [35] PF-05221304 (PF'1304), A LIVER-TARGETED ACETYL-CoA CARBOXYLASE INHIBITOR (ACCI), IN ADULTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DEMONSTRATES ROBUST REDUCTIONS IN LIVER FAT AND ALT - PHASE 2a, DOSE-RANGING STUDY
    Amin, Neeta
    Carvajal-Gonzalez, Santos
    Aggarwal, Naresh
    Tuthill, Theresa
    Inglot, Malgorzata
    Bergman, Arthur
    Esler, William
    HEPATOLOGY, 2019, 70 : 21A - 22A
  • [36] TLC-3595, a selective acetyl-CoA carboxylase 2 (ACC2) inhibitor, improves steatosis and fibrosis in murine models of NASH via pleiotropic mechanisms
    Vijayakumar, Archana
    Murakami, Eisuke
    Huss, Ryan
    Sroda, Natalie
    Shimazaki, Atsuyuki
    Morita, Ippei
    Kato, Hideaki
    Nakai, Manami
    Ohyabu, Naoki
    Subramanian, Mani
    Myers, Robert
    JOURNAL OF HEPATOLOGY, 2023, 78 : S323 - S323
  • [37] Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study
    Amin, Neeta B.
    Darekar, Amanda
    Anstee, Quentin M.
    Wong, Vincent Wai-Sun
    Tacke, Frank
    Vourvahis, Manoli
    Lee, Douglas S.
    Charlton, Michael
    Alkhouri, Naim
    Nakajima, Atsushi
    Yunis, Carla
    BMJ OPEN, 2022, 12 (03): : e056159